Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)

Conditions: Human Papilloma Virus; Cervical Cancer; Vulvar Cancer; Vaginal Cancer; Genital WartsInterventions: Biological: Octavalent HPV with 15 mcg IMX / AAHS; Biological: Octavalent HPV with 30 mcg IMX / AAHS; Biological: Octavalent HPV with 60 mcg IMX / AAHS; Biological: Octavalent HPV with 120 mcg IMX / AAHS; Biological: Comparator: Quadrivalent HPV Vaccine (qHPV), (GARDASIL™)Sponsor: Merck Sharp & Dohme Corp.Completed - verified October 2014

http://clinicaltrials.gov/ct2/show/NCT00851643?lup_s=10%2F09%2F2014&lup_d=30

Source: ClinicalTrials.gov - February 24, 2009 Category: Research Source Type: clinical trials